£22m for London’s innovation economy: WestTech London at the heart of two flagship LIPF programmes
Marking the opening day of London Life Sciences Week, the Mayor of London Sadiq Khan today announces £22m of Local Innovation Partnerships Fund (LIPF) investment into three frontier innovation programmes, leveraging more than £120m of wider combined investment across life sciences and quantum technologies.
We’re proud that Imperial College London and the WestTech London ecosystem are playing leading roles in two of the three successful projects.
- £12m for the Strengthening London Quantum Ecosystem programme, delivered through the London Quantum Cluster, a world-leading coalition founded by UCL, Imperial College London and King’s College London. Spanning both the Knowledge Quarter and the WestTech London innovation ecosystem, the programme will help high-growth quantum companies test technologies, attract investment and accelerate commercialisation. By bringing together universities, global technology companies, investors and innovation districts, the programme will support applications of quantum technologies across healthcare, transport, finance, energy and defence, with future potential ranging from drug discovery to more efficient transport and energy networks.
- £5m for PHIX (Frontier Innovation for Cardiometabolic Disease: Validate and Scale), led by UCLPartners in partnership with Harley Street Health District, AlbionVC and London’s Health Innovation Networks, including Imperial College Health Partners. The programme will help businesses test and scale new health technologies, including innovations that improve the detection and monitoring of high blood pressure and irregular heart rhythms, helping promising healthcare innovations move more quickly from validation to adoption.
This announcement reflects exactly what the Local Innovation Partnerships Fund was designed to do: build on regional strengths, connect world-class research with industry and investment, and translate innovation into growth, jobs and better outcomes for society.
London’s status as global powerhouse in life sciences is formidable. The capital is home to more than 2,700 life sciences companies, 19 of the world’s top 20 pharmaceutical companies, and three of the world’s top 15 universities for health and clinical science. Last year, London attracted more life sciences investment than Shanghai, Tokyo and Singapore combined.
Professor Mary Ryan, Vice Provost (Research and Enterprise) at Imperial College London comments:
“We’re proud to be playing a leading role in multiple Local Innovation Partnership Funding projects for London, boosting new industries and supporting businesses of the future. We have seen firsthand, through the WestTech London ecosystem, the power of bringing together higher education, the public sector and industry to turn research excellence into breakthroughs and businesses which create jobs, drive growth and improve people’s lives.”
That collaborative approach is what makes London’s innovation economy so powerful. By connecting universities, the NHS, businesses, investors and policymakers around shared opportunities, we can accelerate the journey from discovery to impact.
With more than 5,000 innovators, investors and industry leaders gathering in the capital this week for London Life Sciences Week, today’s announcement is another significant step in strengthening London’s position as a global leader in frontier innovation and ensuring that breakthroughs developed here create economic and societal impact far beyond the capital.